1상모집 중
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
연구 개요
Researchers are looking for new vaccines to prevent pneumococcal disease, which is any infection in the lungs or other parts of the body that is caused by a type of bacteria called Streptococcus pneumoniae. V118C is a new vaccine designed to help prevent disease from Streptococcus pneumoniae bacteria. This study will look at V118C in toddlers and infants. The goal of the study is to learn how safe V118C is for children and how well they tolerate it.
- 스폰서
- 리드: 머크(MSD)
- 적응증
- Pneumococcal Infection
- 중재
- V118C (Stage 1), V118C (Stage 2), PCV20 (Stage 1), PCV20 (Stage 2)
- 목표 등록
- 210명
- 시작일
- 2026-01-13
- 완료(예정)
- 2029-05-25
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.